Entero Therapeutics, Inc.
USD2.85
-0.15 (-5.00%)
CEO
Jason David Sawyer
IPO Date
2016-10-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.00
Prev. Close
$3.00
Day Low
$2.82
Day High
$3.15
52W Low
$0.97
52W High
$5.84
Market Cap
$0.01B
Volume
0.09M
| -0.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -438.4% | -229.5% | 0.23 | 1.58 | -0.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -533.5% | -268.9% | 0.32 | 1.37 | -0.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 748.4% | -496.5% | -0.13 | 0.77 | -0.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 1237.2% | -252.8% | -0.24 | 0.51 | -2.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -328.7% | -170.5% | 0.35 | 0.80 | -4.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -302.5% | -181.2% | 0.06 | 1.60 | -4.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -406.2% | -169.4% | 0.15 | 0.79 | -10.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -454.1% | -216.0% | 0.05 | 1.27 | -6.3 |
| -0.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -1.4% | -0.9% | 0.01 | 2.62 | -1.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -1.8% | -1.2% | 0.02 | 2.81 | -1.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -2.2% | -1.5% | 0.01 | 2.90 | -1.4 |
| 31 Dec 2024 | Q4 | 50.0% | -12777.7% | -21.2% | -14.3% | 0.00 | 3.03 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -3.7% | -3.0% | 0.00 | 5.34 | -0.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -12.4% | -10.2% | 0.01 | 5.49 | -0.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 7.2% | 6.1% | 0.09 | 1.21 | 1.0 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -113.8% | -59.6% | 0.23 | 1.58 | -0.3 |